PTC Therapeutics Director Michael Schmertzler sells 24,000 shares for $1.73 million
PTCT•Director share sales disclosed
- PTC Therapeutics director Michael Schmertzler disclosed sales of 24,000 common shares on Aug. 19-20.
- Transactions were priced between $70.78 and $73.67 per share.
- The indirect stake was reported at 1,361,594 shares following the sales.
